Biotech equity research involves researching key biotech companies, analyzing their preclinical and clinical data, and predicting the success of their drug candidates. Scientists are often adept at teasing apart the data and determining whether drug candidates are promising, and whether investing in the company is worthwhile. Over 2 financial quarters, I researched top biotech companies in the Midwest and worked with the team at Aspire Capital to evaluate the company’s value in the current market.
SAMPLE SLIDE DECK
- In-depth analysis of Vical. LINK